ProMetic Life Sciences has received a $4 million follow-on purchase order under a long-term supply agreement with a global pharmaceutical company. The order relates to a Mimetic Ligand affinity adsorbent developed and manufactured by ProMetic’s UK subsidiary, ProMetic Biosciences. It will be supplied during 3Q and 4Q11. The supply agreement includes provisions for the supply of a purification component for the manufacture of a biopharmaceutical product undergoing manufacturing scale-up in antici...